BlackRock's Biotechnology Portfolio

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

Solugen is a carbon negative moleucle factory that replaces petroleum-based products with plant-derived substitutes.

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

Motif is a food technology company that offers plant-based and animal-free food options.

Benson Hill is a provider of crop design platform to develop healthier and more sustainable food and ingredients.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Omega Therapeutics offers a proprietary epigenomic programming platform.

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.